4//SEC Filing
BALLIET JENNIFER 4
Accession 0001077183-20-000041
CIK 0001077183other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:20 PM ET
Size
12.7 KB
Accession
0001077183-20-000041
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Tax Payment
Common Stock
2020-03-01−212→ 22,650 total - Award
Common Stock
2020-03-02+2,330→ 24,980 total - Award
Common Stock
2020-03-02$28.33/sh+15,006$425,120→ 15,006 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (15,006 underlying)
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (20,000 underlying) - 17,496
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (17,496 underlying) - 48,334
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (48,334 underlying)
Footnotes (5)
- [F1]Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock.
- [F2]On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.
Documents
Issuer
NEOGENOMICS INC
CIK 0001077183
Entity typeother
Related Parties
1- filerCIK 0001640500
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 8:20 PM ET
- Size
- 12.7 KB